Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Rheumatology (Oxford, England)|December 13, 2016
Granulomatosis with polyangiitis according to geographic origin and ethnicity: clinical-biological presentation and outcome in a French populationBenjamin Terrier, Agnès Dechartres, Christophe Deligny, et al.
Rheumatology (Oxford, England)|November 28, 2013
Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patientsPierre Charles, Antoine Néel, Nathalie Tieulié, et al.
Rheumatology (Oxford, England)|September 5, 2014
Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomesGonzalo De Luna, Benjamin Terrier, Pierre Kaminsky, et al.
Blood Advances|December 29, 2023
Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trialMaria A Lizarralde-Iragorri, Bindu Parachalil Gopalan, Brenda Merriweather, et al.
The Journal of Rheumatology|July 15, 2022
Antineutrophil Cytoplasm Antibody-Associated Vasculitides Valvular Impairment: Multicenter Retrospective Study and Systematic Review of the LiteratureLina Jeantin, Tiphaine Lenfant, Pierre Bataille, et al.
Kidney Medicine|July 22, 2022
Impact of Kidney Failure Risk Prediction Clinical Decision Support on Monitoring and Referral in Primary Care Management of CKD: A Randomized Pragmatic Clinical TrialLipika Samal, John D D'Amore, Michael P Gannon, et al.
Autoimmunity Reviews|April 29, 2015
ANCA-associated vasculitis in patients with primary Sjögren's syndrome: detailed analysis of 7 new cases and systematic literature reviewDewi Guellec, Emilie Cornec-Le Gall, Matthieu Groh, et al.
Presse Medicale (Paris, France : 1983)|July 10, 2020
ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenanceBenjamin Terrier, Pierre Charles, Olivier Aumaître, et al.
European Journal of Internal Medicine|July 29, 2018
Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective studyMaxime Samson, Hervé Devilliers, Kim Heang Ly, et al.
Blood. Red Cells & Iron|March 11, 2026
Long-term mitapivat treatment is safe and efficacious in patients with sickle cell diseaseAnna Conrey, Nancy Asomaning, Ingrid Frey, et al.
Pageof 11